Feng Y - Search Results

1

Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis.

Yang X, Shen J, Gao Y, Feng Y, Guan Y, Zhang Z, Mankin H, Hornicek FJ, Duan Z. Yang X, et al. Among authors: feng y. Int J Cancer. 2015 Oct 15;137(8):2029-39. doi: 10.1002/ijc.29574. Epub 2015 May 5. Int J Cancer. 2015. PMID: 25904021 Free PMC article.

2

MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.

Osaka E, Yang X, Shen JK, Yang P, Feng Y, Mankin HJ, Hornicek FJ, Duan Z. Osaka E, et al. Among authors: feng y. J Orthop Res. 2014 Aug;32(8):1075-82. doi: 10.1002/jor.22632. Epub 2014 Apr 24. J Orthop Res. 2014. PMID: 24760686 Free PMC article.

3

Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.

Feng Y, Sassi S, Shen JK, Yang X, Gao Y, Osaka E, Zhang J, Yang S, Yang C, Mankin HJ, Hornicek FJ, Duan Z. Feng Y, et al. J Orthop Res. 2015 Feb;33(2):199-207. doi: 10.1002/jor.22745. Epub 2014 Oct 27. J Orthop Res. 2015. PMID: 25348612 Free PMC article.

4

NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo.

Yang X, Feng Y, Gao Y, Shen J, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z. Yang X, et al. Among authors: feng y. Gynecol Oncol. 2015 Apr;137(1):134-42. doi: 10.1016/j.ygyno.2015.02.002. Epub 2015 Feb 10. Gynecol Oncol. 2015. PMID: 25677062

5

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.

Gao Y, Foster R, Yang X, Feng Y, Shen JK, Mankin HJ, Hornicek FJ, Amiji MM, Duan Z. Gao Y, et al. Among authors: feng y. Oncotarget. 2015 Apr 20;6(11):9313-26. doi: 10.18632/oncotarget.3220. Oncotarget. 2015. PMID: 25823654 Free PMC article.

6

Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma.

Feng Y, Shen J, Gao Y, Liao Y, Cote G, Choy E, Chebib I, Mankin H, Hornicek F, Duan Z. Feng Y, et al. Oncotarget. 2015 May 10;6(13):11139-49. doi: 10.18632/oncotarget.3576. Oncotarget. 2015. PMID: 25871477 Free PMC article.

7

CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.

Gao Y, Feng Y, Shen JK, Lin M, Choy E, Cote GM, Harmon DC, Mankin HJ, Hornicek FJ, Duan Z. Gao Y, et al. Among authors: feng y. Sci Rep. 2015 Jun 16;5:11365. doi: 10.1038/srep11365. Sci Rep. 2015. PMID: 26079799 Free PMC article.

8

The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.

Liao Y, Feng Y, Shen J, Hornicek FJ, Duan Z. Liao Y, et al. Among authors: feng y. Cancer Metastasis Rev. 2016 Jun;35(2):151-63. doi: 10.1007/s10555-015-9601-1. Cancer Metastasis Rev. 2016. PMID: 26669603 Review.

9

Clinical and biological significance of PIM1 kinase in osteosarcoma.

Liao Y, Feng Y, Shen J, Gao Y, Cote G, Choy E, Harmon D, Mankin H, Hornicek F, Duan Z. Liao Y, et al. Among authors: feng y. J Orthop Res. 2016 Jul;34(7):1185-94. doi: 10.1002/jor.23134. Epub 2015 Dec 31. J Orthop Res. 2016. PMID: 26687194 Free article.

10

Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray.

Gao Y, Liao Y, Shen JK, Feng Y, Choy E, Cote G, Harmon D, Mankin HJ, Hornicek FJ, Duan Z. Gao Y, et al. Among authors: feng y. J Orthop Res. 2016 Sep;34(9):1606-12. doi: 10.1002/jor.23173. Epub 2016 Feb 2. J Orthop Res. 2016. PMID: 26790551 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,858 results

Search Page

Filters